Business Description
Lineage Cell Therapeutics is a California-based biotechnology company focused on developing therapies that replace damaged or lost cells to treat serious conditions affecting vision, hearing, the nervous system, and metabolism. Its most advanced programs include a retinal cell therapy for age-related macular degeneration and a nerve cell therapy for spinal cord injuries, both currently in clinical trials. The company also has several earlier-stage programs in development, targeting conditions such as hearing loss, diabetes, and photoreceptor damage, and works with outside partners to advance some of these efforts. Formerly known as BioTime Inc., the company has been operating since 1990.
